Molecular Detection of gyrA, parC and oprD Mutation in Pseudomonas aeruginosa Isolates from a University Hospital of Isfahan, Iran during 2016
AbstractBackground: Excessive use of broad-spectrum antibiotics in hospitals has led to the emergence of highly resistant strains of Pseudomonas aeruginosa. The main mechanism of resistance of this bacterium to fluoroquinolones and carbapenems are the modification of type II topoisomerases (DNA gyrase and topoisomerase IV) and alterations in the OprD porin, respectively. The aim of this study was to examine for the occurrence of mutations related to fluoroquinolone resistance of gyrA and parC genes and mutational inactivation of oprD gene of clinical isolates using DNA sequencing technique.Methods: A total of 60 P. aeruginosa isolates were collected from the hospitalized patients in the Intensive Care Units (ICUs) of Al-Zahra hospital located in Isfahan, Iran. The pattern of sensitivity to antibiotics was determined using CLSI disk diffusion and MIC methods. The assay was based on a DNA sequencing method using polymerase chain reaction (PCR) for amplification and sequencing of the selected genes.Results: The results show that replacement of Ile for Thr-83 in gyrA was the only replacement, while other substitutions not observed. No mutations were found in parC. The most frequent amino acid alterations were E185Q, P186G, and V189T, found in five resistance isolates, However, nucleotide insertions and deletions mutations not observed.Conclusion: Our study suggested that mutation of gyrA and oprD genes may play a minor role in fluoroquinolone and carbapenem resistance and other mechanisms may contribute to the fluoroquinolone and carbapenem resistance of P. aeruginosa.
Ozer B, Duran N, Onlen Y, Savas L. Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit. J Antibiot 2012; 65(1): 9–13.
Badamchi, A., Masoumi, H., Javadinia, S., Asgarian, R. and Tabatabaie, A., 2017. Molecular detection of six virulence genes in Pseudomonas aeruginosa isolates detected in children with urinary tract infection. Microb Pathog 107: 44-47.
Farra A, Islam S, Stralfors A, et al. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem. Int J Antimicrob Agents 2008; 31(5): 427–33.
Fazeli H, Havaei SA, Solgi H, et al. Pattern of antibiotic resistance in Pesudomonas aeruginosa isolated from intensive care unit, Isfahan, Iran. Journal of Isfahan Medical School 2013; 31(232): 432-438.
Gutierrez O, Juan C, Cercenado E, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother 2007; 51(12): 4329–35.
Naenna P, Noisumdaeng P, Pongpech P, et al. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates. Southeast Asian J Trop Med Public Health 2010; 41(3): 614–24.
Mohammadzadeh M, Tavakoli M, Mohebi A, et al. Phenotypic and genotypic detection of metallo-beta-lactamases among imipenem resistant gram negative isolates. J Med Bacteriol, 2016; 5(1-2): 36-42.
Lee JY, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents 2012; 40(2): 168–72.
Chakraborty D, Basu S, Das S. A study on infections caused by metallo beta lactamase producing gram negative bacteria in intensive care unit patients. Am J Infect Dis 2010; 6: 34–9.
Matsumoto M, Shigemura K, Shirakawa T, et al. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography. Int J Antimicrob Agents 2012; 40(5): 440–4.
Meletis G, Exindari M, Vavatsi N, et al. Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia 2012; 16(4): 303–307.
Ocampo-Sosa AA, Cabot G, Rodriguez C, et al. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa Isolated from patients with bacteremia in a spanish multicenter study. Antimicrob Agents Chemother 2012; 56(4): 1703–1713.
Rahbar M, Kabeh-Monnavar M, Khadem-Vatan K, et al. Carbapenem resistance in gram negative bacilli isolates in an iranian 1000-bed tertiary hospital. Pak J Med Sci 2008; 24(4): 537-40.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. CLSI document M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute 2012; 32(3).
Aakasaka T, Tanaka M, Yamaguchi A, et al. Type II Topoisomerase Mutations in Fluoroquinolone-Resistant Clinical Strains of Pseudomonas aeruginosa Isolated in 1998 and 1999: Role of Target Enzyme in Mechanism of Fluoroquinolone Resistance. Antimicrob Agents Chemother 2001; 45(8): 2263-8.
Naenna P, Noisumdaeng P, Pongpech P, et al. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates. Southeast Asian J Trop Med Public Health 2010; 41(3): 614-24.
Zabihi T, Karbasizade V, Ahadi, AM. Comparative Analysis of Three Methods for Determination of Imipenem Resistance in Pseudomonas aeruginosa. J Med Bacteriol 2015; 4(5, 6): 37-41.
Salma RM, Dabboussi FA, Kassaa IO, K et al. gyrA and parC Mutations in Quinolone-Resistant Clinical Isolates of Pseudomonas aeruginosa from Nini Hospital in North Lebanon. Intl J Microbiol Res 2012; 19(1): 77–81.
Wydmuch Z, Skowronek-Ciolec O, Choleva K, et al. gyrA Mutations in Ciprofloxacin-resistant Clinical Isolates of Pseudomonas aeruginosa in a Silesian Hospital in Poland. Pol J Microbiol 2005; 54(3): 201–6.
Wang J, Zhou J-y, Qu T-t, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int J Antimicrob Agents 2010; 35(5): 486–91.
Lepelletier D, Cady A, Caroff N, et al. Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms. Diagn Microbiol Infect Dis 2010; 66(1):1–6.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.